amrinone has been researched along with Blood Loss, Postoperative in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Excerpt | Relevance | Reference |
---|---|---|
"With the dosage regimen used, supplemented with epinephrine, amrinone provides a higher cardiac output and more favorable oxygen dynamics than a combination of dopamine and nitroglycerin." | 2.69 | Amrinone versus dopamine and nitroglycerin in neonates after arterial switch operation for transposition of the great arteries. ( Happonen, JM; Laitinen, P; Peltola, K; Rautiainen, P; Sairanen, H, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Laitinen, P | 1 |
Happonen, JM | 1 |
Sairanen, H | 1 |
Peltola, K | 1 |
Rautiainen, P | 1 |
1 trial available for amrinone and Blood Loss, Postoperative
Article | Year |
---|---|
Amrinone versus dopamine and nitroglycerin in neonates after arterial switch operation for transposition of the great arteries.
Topics: Adrenergic Agonists; Amrinone; Blood Circulation; Cardiac Output; Cardiopulmonary Bypass; Cardiotoni | 1999 |